TruSight Oncology Comprehensive (EU)

In this data sheet, Illumina presents TruSight™ Oncology Comprehensive (EU), a CE-marked, IVD, kitted solution for next-generation sequencing based comprehensive genomic profiling in cancer diagnostics. Illumina highlights its integrated workflow for DNA and RNA analysis of 517 clinically relevant cancer-associated genes, including library preparation, sequencing on the NextSeq™ 550Dx System, and automated variant calling and report generation. This solution enables labs to deliver timely, reliable, and clinically actionable results with streamlined implementation, reduced sample requirements, and minimized verification effort compared to laboratory-developed tests.